John W. Eikelboom

98.2k citations
867 papers · 75.2k · 45 hit papers · h-index 118

Impact in

Papers in

John W. Eikelboom

835 papers receiving 71k citations

John W. Eikelboom's Hit Papers

Colchicine for secondary prevention of vascular events: a meta-analysis of trials 2025 · 30 citations
300+2+4Years since publication5001k1.5k2k

Peers

John W. Eikelboom
Comparison fields: 5 of 181
  • Internal Medicine 9.4k
  • Cardiology and Cardiovascular Medicine 42.6k
  • Hematology 6k
  • Biochemistry 2.6k
  • Critical Care and Intensive Care Medicine 858
Replace Mark Andrew Crowther with:
Mark Andrew Crowther Canada
Jeffrey Ian Weitz Canada
Lars C. Wallentin Sweden
Adam Torbicki Poland
Ulf Landmesser Germany
Christopher Bull Granger United States
Michał Tendera Poland
Jean‐Philippe Collet France
Sam Schulman Canada
Philippe Gabríel Steg France
John W. Eikelboom relative to Mark Andrew Crowther Canada Mark Andrew Crowther's profile →
Citations per field
00.5×2×3×3.6×
Mark Andrew Crowther · 1×
Citations per year

Countries citing papers authored by John W. Eikelboom

Since Specialization
Citations

This map shows the geographic impact of John W. Eikelboom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Eikelboom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Eikelboom more than expected).

Fields of papers citing papers by John W. Eikelboom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Eikelboom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Eikelboom. The network helps show where John W. Eikelboom may publish in the future.

Co-authors

The 25 scholars most cited alongside John W. Eikelboom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John W. Eikelboom Line = papers co-authored together John W. Eikelboom links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 867 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Hit paper breakdown →
20098958
2
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
Hit paper breakdown →
20113752
3
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
Hit paper breakdown →
20202275
4
Apixaban in Patients with Atrial Fibrillation
Hit paper breakdown →
20111917
5
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
Hit paper breakdown →
20171792
6
Colchicine in Patients with Chronic Coronary Disease
Hit paper breakdown →
20201694
7
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
Hit paper breakdown →
20131134
8
Idarucizumab for Dabigatran Reversal
Hit paper breakdown →
20151133
9
Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
Hit paper breakdown →
20061078
10
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
Hit paper breakdown →
2011917
11
Homocysteine and vascular disease
Hit paper breakdown →
1999899
12
Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events
Hit paper breakdown →
2002879
13
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Hit paper breakdown →
2012879
14
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
Hit paper breakdown →
2017852
15
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis
Hit paper breakdown →
2009851
16
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
Hit paper breakdown →
2010810
17
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Hit paper breakdown →
1999753
18
Myocardial Injury after Noncardiac Surgery
Hit paper breakdown →
2014735
19
The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
Hit paper breakdown →
2013723
20
Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
Hit paper breakdown →
2008716

About John W. Eikelboom

John W. Eikelboom is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Hematology, Biochemistry and Rheumatology, having authored 867 papers that have together received 75.2k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (310 papers), Antiplatelet Therapy and Cardiovascular Diseases (207 papers), Venous Thromboembolism Diagnosis and Management (131 papers), Blood Coagulation and Thrombosis Mechanisms (64 papers), Acute Myocardial Infarction Research (50 papers), Blood transfusion and management (32 papers), Folate and B Vitamins Research (29 papers) and Acute Ischemic Stroke Management (27 papers). The work is most often cited by research in Internal Medicine (9.4k citations), Cardiology and Cardiovascular Medicine (42.6k citations), Hematology (6k citations), Biochemistry (2.6k citations) and Critical Care and Intensive Care Medicine (858 citations). John W. Eikelboom has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Salim Yusuf, Graeme J. Hankey, Stuart J. Connolly, Lars C. Wallentin, Jeffrey Ian Weitz, Michael D. Ezekowitz, Paul A. Reilly, Jonas Oldgren, Jack Hirsh and Janice M. Pogue. Their work appears in journals such as Circulation, European Heart Journal, Journal of the American College of Cardiology, Journal of Thrombosis and Haemostasis and Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact